Vidipha Central Pharmaceutical JSC (HOSE:VDP)

HOSE:VDP Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2008
Period Ending	Sep 30, 2026	Dec 31, 2025	Jan 1, 2025	Dec 31, 2023	Jan 1, 2023	Dec 31, 2008
Cash & Equivalents	357,680	180,866	123,831	213,988	88,123	18,666
Short-Term Investments	90,727	252,490	192,790	119,000	209,692	54,500
Cash & Short-Term Investments	448,408	433,356	316,621	332,988	297,815	73,166
Cash Growth	-	36.87%	-4.92%	11.81%	307.04%	23.57%
Accounts Receivable	241,343	193,355	230,480	199,693	187,387	41,717
Other Receivables	5,943	5,955	17,047	19,523	24,175	42.49
Receivables	247,286	199,310	247,527	219,216	212,187	41,760
Inventory	302,677	283,627	346,482	296,736	341,329	33,507
Prepaid Expenses	3,403	1,591	2,416	2,019	373.94	1.42
Other Current Assets	748.08	3,785	9,173	24,058	63,986	3,558
Total Current Assets	1,002,522	921,669	922,220	875,016	915,692	151,992
Property, Plant & Equipment	124,392	141,195	155,646	172,255	151,140	26,045
Long-Term Investments	-	-	-	5,000	5,010	4,165
Other Intangible Assets	45,715	44,372	39,179	38,926	27,822	9,236
Other Long-Term Assets	303.84	8,786	8,401	1,245	204.32	-
Total Assets	1,172,933	1,116,021	1,125,829	1,093,445	1,102,194	191,437

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2008
Period Ending	Sep 30, 2026	Dec 31, 2025	Jan 1, 2025	Dec 31, 2023	Jan 1, 2023	Dec 31, 2008
Accounts Payable	38,050	104,417	53,269	36,594	71,407	13,074
Accrued Expenses	13,093	37,120	50,788	40,518	53,455	1,356
Short-Term Debt	189,252	198,387	258,438	273,139	336,307	-
Current Income Taxes Payable	2,998	7,540	3,132	-	4,736	674.91
Other Current Liabilities	139,963	18,485	8,432	11,211	9,696	6,658
Total Current Liabilities	383,357	365,949	374,058	361,463	475,601	21,762
Other Long-Term Liabilities	-	-	-	-	-	292.48
Total Liabilities	383,357	365,949	374,058	361,463	475,601	22,055

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2008
Period Ending	Sep 30, 2026	Dec 31, 2025	Jan 1, 2025	Dec 31, 2023	Jan 1, 2023	Dec 31, 2008
Common Stock	220,834	220,834	220,834	184,029	168,319	60,000
Additional Paid-In Capital	179,852	179,852	179,852	216,657	176,040	61,803
Retained Earnings	388,891	349,386	351,085	331,296	282,235	33,916
Comprehensive Income & Other	-	-	-	-	-	13,664
Shareholders' Equity	789,577	750,072	751,771	731,982	626,593	169,382
Total Liabilities & Equity	1,172,933	1,116,021	1,125,829	1,093,445	1,102,194	191,437

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2008
Period Ending	Sep 30, 2026	Dec 31, 2025	Jan 1, 2025	Dec 31, 2023	Jan 1, 2023	Dec 31, 2008
Total Debt	189,252	198,387	258,438	273,139	336,307	-
Net Cash (Debt)	259,156	234,969	58,183	59,848	-38,491	73,166
Net Cash Growth	-	303.84%	-2.78%	-	-	23.57%
Net Cash Per Share	11735.32	10640.06	2634.69	2963.04	-1905.67	10160.92
Filing Date Shares Outstanding	22.08	22.08	22.08	22.08	20.2	7.2
Total Common Shares Outstanding	22.08	22.08	22.08	22.08	20.2	7.2
Working Capital	619,166	555,719	548,162	513,553	440,091	130,230
Book Value Per Share	35754.32	33965.43	34042.38	33146.14	31022.11	23525.33
Tangible Book Value	743,862	705,700	712,592	693,056	598,772	160,147
Tangible Book Value Per Share	33684.23	31956.16	32268.25	31383.47	29644.68	22242.61
Buildings	168,827	166,402	155,975	149,233	124,746	23,592
Machinery	264,048	262,557	258,001	251,362	217,337	42,578
Construction In Progress	425	86.5	108.98	203.75	11,500	239.83

Data Source: S&P Global Market Intelligence Last updated: Oct 21, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error